A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk
ContributorsWeisskopf, Etienne; Guidi, Monia; Fischer, Céline J; Bickle Graz, Myriam; Beaufils, Etienne; Nguyen, Kim An; Morisod Harari, Mathilde; Rouiller, Sylvie; Rothenburger, Sophie; Gaucherand, Pascal; Kassai-Koupai, Behrouz; Borradori Tolsa, Cristina; Epiney, Manuela; Tolsa, Jean-François; Vial, Yvan; Hascoët, Jean-Michel; Claris, Olivier; Eap, Chin Bin; Panchaud-Monnat, Alice; Csajka, Chantal
Published inBritish Journal of Clinical Pharmacology, vol. 86, no. 8, p. 1642-1653
Publication date2020
Abstract
Keywords
- Animals
- Breast Feeding
- Citalopram/pharmacokinetics
- Female
- Humans
- Infant
- Milk
- Human/metabolism
- Pharmaceutical Preparations
- Pregnancy
- Prospective Studies
- Serotonin Uptake Inhibitors/pharmacokinetics
Research groups
Citation (ISO format)
WEISSKOPF, Etienne et al. A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk. In: British Journal of Clinical Pharmacology, 2020, vol. 86, n° 8, p. 1642–1653. doi: 10.1111/bcp.14278
Main files (1)
Article (Published version)
Identifiers
- PID : unige:155525
- DOI : 10.1111/bcp.14278
- PMID : 32162723
Commercial URLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373710/
Journal ISSN0306-5251